March 13, 2017

Analysis: AksharChem (India) Limited

www.drvijaymalik.com has a dedicated section for investment & stock specific queries of readers: “Ask Your Queries”. Over time, readers have asked queries about multiple stocks in this section. Answers to these queries have been done post preliminary analysis of the stocks under consideration. Such analysis has been found helpful by readers.

“Analysis” series is an attempt to summarize & share with all the readers, the key questions and their answers, which have featured on “Ask Your Queries” section. The primary aim of this new feature is to share the knowledge with all the readers of the website.

The current section of this series, “Q&A” covers AksharChem (India) Limited, an Indian manufacturer of dye intermediates (Vinyl Sulphone) and pigments (CPC Green and CPC Violet) based out of Gujarat.

AksharChem (India) Limited, equity research report, analysis, dye intermediates, Vinyl Sulphone, pigments, CPC Green, CPC Violet, CPC Blue, CPC Beta Blue, Asahi Songwon Colors Limited, Paru Jaykrishna, Munjal, Gokul

March 3, 2017

Analysis: Machino Plastics Limited

www.drvijaymalik.com has a dedicated section for investment & stock specific queries of readers: “Ask Your Queries”. Over time, readers have asked queries about multiple stocks in this section. Answers to these queries have been done post preliminary analysis of the stocks under consideration. Such analysis has been found helpful by readers.

“Analysis” series is an attempt to summarize & share with all the readers, the key questions and their answers, which have featured on “Ask Your Queries” section. The primary aim of this new feature is to share the knowledge with all the readers of the website.

The current section of this series, “Q&A” covers Machino Plastics Limited, an Indian auto ancillary player specializing in manufacturing injection plastic moulded parts for key players like Maruti Suzuki India, Suzuki Motorcycle India, Volvo Eicher, Hero Motors etc.

Analysis Equity Research Report Machino Plastics Limited, manufacturing injection plastic moulded parts for Maruti Suzuki India, Suzuki Motorcycle India, Volvo Eicher, Hero Motors, Caparo Maruti Limited

February 27, 2017

Analysis: Wonderla Holidays Limited

www.drvijaymalik.com has a dedicated section for investment & stock specific queries of readers: “Ask Your Queries”. Over time, readers have asked queries about multiple stocks in this section. Answers to these queries have been done post preliminary analysis of the stocks under consideration. Such analysis has been found helpful by readers.

“Analysis” series is an attempt to summarize & share with all the readers, the key questions and their answers, which have featured on “Ask Your Queries” section. The primary aim of this new feature is to share the knowledge with all the readers of the website.

The current section of this series, “Analysis” covers Wonderla Holidays Limited, a leading player in the Indian amusement park industry with operational parks in the cities of Bangalore, Hyderabad and Cochin.
Analysis Wonderla Holidays Limited equity research report, Wonderla Bangalore, Wonderla Cochin, Kochi, Wonderla Hyderabad, Dr Vijay Malik, Dr Stock, Mr. Kochouseph Chittilappilly, Mr. Arun Chittilappilly

February 24, 2017

Q&A: Granules India, Divi's Laboratories and Mirza International Limited

www.drvijaymalik.com has a section dedicated to answering queries of readers: “Ask Your Queries”. Over time, many readers have asked their queries related to many aspects of stock analysis and sought clarifications about investing. I have responded to these queries as replies to their comments.

“Q&A” series is an attempt to share the queries & their responses, which have featured on “Ask Your Queries” section, with all the readers. The primary aim of this new feature is to share the knowledge with other readers of the website, who might have similar queries.

The current article in this series provides responses related to:
  • Granules India Limited
  • Divi’s Laboratories Limited
  • Mirza International Limited
Answers to readers' queries on analysis of Granules India, Divi's Laboratories and Mirza International Limited

February 23, 2017

Q&A: MBL Infrastructure, Owner's Earnings, Mirza International and Equity Dilution

www.drvijaymalik.com has a section dedicated to answering queries of readers: “Ask Your Queries”. Over time, many readers have asked their queries related to many aspects of stock analysis and sought clarifications about investing. I have responded to these queries as replies to their comments.

“Q&A” series is an attempt to share the queries & their responses, which have featured on “Ask Your Queries” section, with all the readers. The primary aim of this new feature is to share the knowledge with other readers of the website, who might have similar queries.

The current article in this series provides responses related to:
  • MBL Infrastructure Limited
  • Owner’s Earnings & FCF
  • Mirza International Limited
  • EBITDA, equity dilution and extinguishment of shares
Answers to readers' queries on MBL Infrastructure Limited, Owner's earnings vs Free cash flow (FCF), Mirza International Limited, EBITDA, Equity Dilution, buy back, extinguishment of shares

February 22, 2017

Participants' Experiences: "Peaceful Investing" Workshop, Pune, Feb 12, 2017

The “Peaceful Investing” workshop was held in Pune on February 12, 2017. The workshop was aimed at sharing equity investing knowledge with the participants that could help them gain confidence while taking their equity investment decisions.

This workshop was our first in Pune and the presence of participants coming to Pune from Bangalore, Indore, Kolhapur, Mumbai and different areas of Maharashtra made it a special occasion for us.

Peaceful fundamental value stock Investing Workshop by Dr Vijay Malik Pune Hotel Sagar Plaza. Full-Day fundamental Value Investing Workshop by Dr Stock

February 21, 2017

Analysis: Divi's Laboratories Limited

www.drvijaymalik.com has a dedicated section for investment & stock specific queries of readers: “Ask Your Queries”. Over time, readers have asked queries about multiple stocks in this section. Answers to these queries have been done post preliminary analysis of the stocks under consideration. Such analysis has been found helpful by readers.

“Analysis” series is an attempt to summarize & share with all the readers, the key questions and their answers, which have featured on “Ask Your Queries” section. The primary aim of this new feature is to share the knowledge with all the readers of the website.

The current section of this series, “Analysis” covers Divi’s Laboratories Limited, a Hyderabad-based Indian pharmaceutical manufacturer, which focuses on making active pharmaceutical ingredients (API) and intermediates as primary business activities.
Analysis Divi’s Laboratories Limited Equity research report, Hyderabad, active pharmaceutical ingredients, API, intermediates, Dr Vijay Malik, Dr Stock, Management analysis

February 18, 2017

Register for "Peaceful Investing Workshop", Mumbai, May 14, 2017

One of the key methods to generate significant wealth from stock markets is to buy & hold fundamentally sound stocks over long periods of times extending to years and many times to decades. However, such long investing duration invariably contains periods of exuberance & distress where the market price rises & falls significantly. It leads to strong emotional reactions from investors that make holding stocks for the long term a difficult proposition.

Therefore, the patience to hold stocks in fluctuating markets requires very high level of conviction from the investor in her investing decisions.

“Peaceful Investing” workshop aims to focus on stock selection and analysis skills, which would make us much more confident about our stock decisions. It would ensure that our faith would not shake with day to day market price fluctuations and we would be able to reap true benefits of stock markets to fulfil our dream of financial independence.

Full day, fundamental, stock, investing, workshop, focusing on value investing, by Dr Vijay Malik, at Mumbai, on May 14, 2017 at Hotel Mirage, Andheri Kurla Road

February 9, 2017

Analysis: Granules India Limited

www.drvijaymalik.com has a dedicated section for investment & stock specific queries of readers: “Ask Your Queries”. Over time, readers have asked queries about multiple stocks in this section. Answers to these queries have been done post preliminary analysis of the stocks under consideration. Such analysis has been found helpful by readers.

Q&A Series is an attempt to summarize & share with all the readers, the key questions and their answers, which have featured on “Ask Your Queries” section. The primary aim of this new feature is to share the knowledge with all the readers of the website.

The current section of this series, “Q&A” covers Granules India Limited, a Hyderabad-based Indian integrated pharmaceutical manufacturer, which focuses on making active pharmaceutical ingredients (API), pharmaceutical formulation intermediates (PFI) and finished dosages (FD) as primary business activities.
Equity research report analysis Granules India Limited, active pharmaceutical ingredients API, pharmaceutical formulation intermediates PFI and finished dosages FD, Actus Pharma Limited, Omnichem